189 related articles for article (PubMed ID: 29201193)
1. Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients.
Zuo Z; Fan H; Tang XD; Chen YM; Xun LT; Li Y; Song ZJ; Zhai HQ
Exp Ther Med; 2017 Nov; 14(5):4887-4895. PubMed ID: 29201193
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
[TBL] [Abstract][Full Text] [Related]
3. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy.
Schulz C; Schütte K; Vilchez-Vargas R; Vasapolli R; Malfertheiner P
Dig Dis; 2019; 37(2):161-169. PubMed ID: 30428474
[TBL] [Abstract][Full Text] [Related]
5. The role of microbiota in hepatic encephalopathy.
Bajaj JS
Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
Bajaj JS; Heuman DM; Sanyal AJ; Hylemon PB; Sterling RK; Stravitz RT; Fuchs M; Ridlon JM; Daita K; Monteith P; Noble NA; White MB; Fisher A; Sikaroodi M; Rangwala H; Gillevet PM
PLoS One; 2013; 8(4):e60042. PubMed ID: 23565181
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
[TBL] [Abstract][Full Text] [Related]
8. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
9. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
10. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
Fiorillo A; Gallego JJ; Casanova-Ferrer F; Urios A; Ballester MP; San Miguel T; Megías J; Kosenko E; Tosca J; Rios MP; Escudero-García D; Montoliu C
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834174
[TBL] [Abstract][Full Text] [Related]
12. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
Bajaj JS; Fagan A; White MB; Wade JB; Hylemon PB; Heuman DM; Fuchs M; John BV; Acharya C; Sikaroodi M; Gillevet PM
Am J Gastroenterol; 2019 Jul; 114(7):1080-1090. PubMed ID: 30816877
[TBL] [Abstract][Full Text] [Related]
13. Probiotics in management of hepatic encephalopathy.
Sharma BC; Singh J
Metab Brain Dis; 2016 Dec; 31(6):1295-1301. PubMed ID: 27121846
[TBL] [Abstract][Full Text] [Related]
14. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
Zhang Y; Feng Y; Cao B; Tian Q
Int J Clin Exp Med; 2015; 8(2):2954-7. PubMed ID: 25932262
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota: its role in hepatic encephalopathy.
Rai R; Saraswat VA; Dhiman RK
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
Viramontes Hörner D; Avery A; Stow R
J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
[TBL] [Abstract][Full Text] [Related]
17. Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis.
Luo M; Hu FR; Xin RJ; Yao L; Hu SJ; Bai FH
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):797-807. PubMed ID: 35942803
[TBL] [Abstract][Full Text] [Related]
18. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
19. Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis.
Haraguchi M; Miuma S; Masumoto H; Ichikawa T; Kanda Y; Sasaki R; Fukushima M; Miyaaki H; Taura N; Nakao K
Hepatol Int; 2019 Jul; 13(4):482-489. PubMed ID: 31290070
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
Cai XJ; Wang L; Hu CM
J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
